Myelination of the nervous system: Mechanisms and functions

Annual Review of Cell and Developmental Biology

Volumn 30, Issue , 2014, Pages 503-533

  Nave, Klaus Armin ^a   Werner, Hauke B ^a  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Axoglial signaling; Brain energy metabolism; Myelin sheath; Neural plasticity; Oligodendrocyte; Schwann cell

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; GLUCOSE; MYELIN PROTEIN; N-ACETYLASPARTATE;

ANALOGS AND DERIVATIVES; ANIMAL; CENTRAL NERVOUS SYSTEM; CYTOSKELETON; DEMYELINATING DISEASE; ELECTRON MICROSCOPY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INFLAMMATION; LEUKOENCEPHALOPATHY; METABOLISM; MOUSE; MYELIN SHEATH; NERVE CELL PLASTICITY; NERVE FIBER; OLIGODENDROGLIA; PATHOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; SCHWANN CELL; SYNAPTIC TRANSMISSION; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ASPARTIC ACID; AXONS; CENTRAL NERVOUS SYSTEM; CHARCOT-MARIE-TOOTH DISEASE; CYTOSKELETON; DEMYELINATING DISEASES; GLUCOSE; HUMANS; INFLAMMATION; LEUKOENCEPHALOPATHIES; MICE; MICROSCOPY, ELECTRON; MYELIN PROTEINS; MYELIN SHEATH; NEURONAL PLASTICITY; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; SCHWANN CELLS; SYNAPTIC TRANSMISSION;

EID: 84925267195     PISSN: 10810706     EISSN: 15308995     Source Type: Book Series    
DOI: 10.1146/annurev-cellbio-100913-013101     Document Type: Chapter

References (305)

1. Aggarwal S, Snaidero N, Pahler G, Frey S, Sanchez P, et al. 2013. Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork. PLOS Biol. 11:e1001577
2. Aggarwal S, Yurlova L, Snaidero N, Reetz C, Frey S, et al. 2011. A size barrier limits protein diffusion at the cell surface to generate lipid-rich myelin-membrane sheets. Dev. Cell 21:445-56
3. Aguzzi A, Barres BA, Bennett ML. 2013. Microglia: scapegoat, saboteur, or something else? Science 339:156-61
4. Ahrendsen JT, Macklin W. 2013. Signaling mechanisms regulating myelination in the central nervous system. Neurosci. Bull. 29:199-215
5. Almeida RG, Czopka T, Ffrench-Constant C, Lyons DA. 2011. Individual axons regulate the myelinating potential of single oligodendrocytes in vivo. Development 138:4443-50
6. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL. 2002. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 22:6458-70
7. Anzini P, Neuberg DH, Schachner M, Nelles E, Willecke K, et al. 1997. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17:4545-51
8. Arroyo EJ, Scherer SS. 2000. On the molecular architecture of myelinated fibers. Histochem. Cell Biol. 113:1-18
9. Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, et al. 2012. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron 75:633-47
10. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, et al. 2005. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 11:966-72
11. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, et al. 2009. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 132:465-81
12. Bakhti M, Snaidero N, Schneider D, Aggarwal S, Mobius W, et al. 2013. Loss of electrostatic cell-surface repulsion mediates myelin membrane adhesion and compaction in the central nervous system. Proc. Natl. Acad. Sci. USA 110:3143-48
13. Bakiri Y, Karadottir R, Cossell L, Attwell D. 2011. Morphological and electrical properties of oligodendrocytes in the white matter of the corpus callosum and cerebellum. J. Physiol. 589:559-73
14. Barbarese E, Brumwell C, Kwon S, Cui H, Carson JH. 1999. RNA on the road to myelin. J. Neurocytol. 28:263-70
15. Barca-Mayo O, Lu QR. 2012. Fine-tuning oligodendrocyte development by microRNAs. Front. Neurosci. 6:13
16. Baron W, Hoekstra D. 2010. On the biogenesis of myelin membranes: sorting, trafficking and cell polarity. FEBS Lett. 584:1760-70
17. Barrette B, Nave KA, Edgar JM. 2013. Molecular triggers of neuroinflammation in mouse models of demyelinating diseases. Biol. Chem. 394:1571-81
18. Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, et al. 2011. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc. Natl. Acad. Sci. USA 108:E952-61
19. Bengtsson SL, Nagy Z, Skare S, Forsman L, Forssberg H, Ullen F. 2005. Extensive piano practicing has regionally specific effects on white matter development. Nat. Neurosci. 8:1148-50
20. Bermingham JR Jr, Scherer SS, O'Connell S, Arroyo E, Kalla KA, et al. 1996. Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes Dev. 10:1751-62
21. Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, et al. 2013. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158
22. Biname F, Sakry D, Dimou L, Jolivel V, Trotter J. 2013. NG2 regulates directional migration of oligodendrocyte precursor cells via Rho GTPases and polarity complex proteins. J. Neurosci. 33:10858-74
23. Bizzozero OA, Bixler HA, Davis JD, Espinosa A, Messier AM. 2001. Chemical deacylation reduces the adhesive properties of proteolipid protein and leads to decompaction of the myelin sheath. J. Neurochem. 76:1129-41
24. Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, et al. 2010. Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci. 13:310-18
25. Brinkmann BG, Agarwal A, Sereda MW, Garratt AN, Muller T, et al. 2008. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59:581-95
26. Brockschnieder D, Sabanay H, Riethmacher D, Peles E. 2006. Ermin, a myelinating oligodendrocyte-specific protein that regulates cell morphology. J. Neurosci. 26:757-62
27. Brosius Lutz A, Barres BA. 2014. Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev. Cell 28:7-17
28. Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. 2010. Leukoencephalopathy with vanishing white matter: a review. J. Neuropathol. Exp. Neurol. 69:987-96
29. Bunge RP. 1968. Glial cells and the central myelin sheath. Physiol. Rev. 48:197-251
30. Buser AM, Erne B, Werner HB, Nave KA, Schaeren-Wiemers N. 2009. The septin cytoskeleton in myelinating glia. Mol. Cell. Neurosci. 40:156-66
31. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. 2008. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28:264-78
32. Capani F, Ellisman MH, Martone ME. 2001. Filamentous actin is concentrated in specific subpopulations of neuronal and glial structures in rat central nervous system. Brain Res. 923:1-11
33. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, et al. 2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326:818-23
34. Chan JR, Jolicoeur C, Yamauchi J, Elliott J, Fawcett JP, et al. 2006. The polarity protein Par-3 directly interacts with p75NTR to regulate myelination. Science 314:832-36
35. Chan JR, Watkins TA, Cosgaya JM, Zhang C, Chen L, et al. 2004. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43:183-91
36. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, et al. 2000. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc. Natl. Acad. Sci. USA 97:7585-90
37. Chavada G, Willison HJ. 2012. Autoantibodies in immune-mediated neuropathies. Curr. Opin. Neurol. 25:550-55
38. Chen Y, Wu H, Wang S, Koito H, Li J, et al. 2009. The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination. Nat. Neurosci. 12:1398-406
39. Chong SY, Rosenberg SS, Fancy SP, Zhao C, Shen YA, et al. 2012. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination. Proc. Natl. Acad. Sci. USA 109:1299-304
40. Chrast R, Saher G, Nave KA, Verheijen MH. 2011. Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J. Lipid Res. 52:419-34
41. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, et al. 1996. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86:209-19
42. Colman DR, Kreibich G, Frey AB, Sabatini DD. 1982. Synthesis and incorporation of myelin polypeptides into CNS myelin. J. Cell Biol. 95:598-608
43. Cosgaya JM, Chan JR, Shooter EM. 2002. The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298:1245-48
44. Court FA, Hendriks WT, MacGillavry HD, Alvarez J, van Minnen J. 2008. Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system. J. Neurosci. 28:11024-29
45. Court FA, Hewitt JE, Davies K, Patton BL, Uncini A, et al. 2009. A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments. J. Neurosci. 29:3908-19
46. Czopka T, Ffrench-Constant C, Lyons DA. 2013. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev. Cell 25:599-609
47. Dagley LF, White CA, Liao Y, Shi W, Smyth GK, et al. 2014. Quantitative proteomic profiling reveals novel region-specific markers in the adult mouse brain. Proteomics 14:241-61
48. de Monasterio-Schrader P, Jahn O, Tenzer S, Wichert SP, Patzig J, Werner HB. 2012. Systematic approaches to central nervous system myelin. Cell Mol. Life Sci. 69:2879-94
49. de Monasterio-Schrader P, Patzig J, Mobius W, Barrette B, Wagner TL, et al. 2013. Uncoupling of neuroinflammation from axonal degeneration in mice lacking the myelin protein tetraspanin-2. Glia 61:1832-47
50. de Waegh SM, Lee VM, Brady ST. 1992. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-63
51. Depienne C, Bugiani M, Dupuits C, Galanaud D, Touitou V, et al. 2013. Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study. Lancet Neurol. 12:659-68
52. Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, et al. 2009. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl. Acad. Sci. USA 106:8302-7
53. Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, et al. 2013. A regenerative approach to the treatment of multiple sclerosis. Nature 502:327-32
54. Devaux J, Gow A. 2008. Tight junctions potentiate the insulative properties of small CNS myelinated axons. J. Cell Biol. 183:909-21
55. Eckhardt M. 2008. The role and metabolism of sulfatide in the nervous system. Mol. Neurobiol. 37:93-103
56. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, et al. 2009. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 57:1815-24
57. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, et al. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J. Cell Biol. 166:121-31
58. Edgar N, Sibille E. 2012. A putative functional role for oligodendrocytes in mood regulation. Transl. Psychiatry 2:e109
59. Edvardson S, Hama H, Shaag A, Gomori JM, Berger I, et al. 2008. Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am. J. Hum. Genet. 83:643-48
60. Emery B, Agalliu D, Cahoy JD, Watkins TA, Dugas JC, et al. 2009. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138:172-85
61. Erblich B, Zhu L, Etgen AM, Dobrenis K, Pollard JW. 2011. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLOS ONE 6:e26317
62. Etienne-Manneville S. 2008. Polarity proteins in glial cell functions. Curr. Opin. Neurobiol. 18:488-94
63. Fancy SP, Chan JR, Baranzini SE, Franklin RJ, Rowitch DH. 2011. Myelin regeneration: a recapitulation of development? Annu. Rev. Neurosci. 34:21-43
64. Feltri ML, Graus Porta D, Previtali SC, Nodari A, Migliavacca B, et al. 2002. Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons. J. Cell Biol. 156:199-209
65. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt. 3):393-99
66. Fewou SN, Fernandes A, Stockdale K, Francone VP, Dupree JL, et al. 2010. Myelin protein composition is altered in mice lacking either sulfated or both sulfated and non-sulfated galactolipids. J. Neurochem. 112:599-610
67. Fewou SN, Ramakrishnan H, Bussow H, Gieselmann V, Eckhardt M. 2007. Down-regulation of polysialic acid is required for efficient myelin formation. J. Biol. Chem. 282:16700-11
68. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31:361-70
69. Filbin MT. 2003. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4:703-13
70. Filbin MT, Walsh FS, Trapp BD, Pizzey JA, Tennekoon GI. 1990. Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344:871-72
71. Finzsch M, Schreiner S, Kichko T, Reeh P, Tamm ER, et al. 2010. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J. Cell Biol. 189:701-12
72. Frühbeis C, Fröhlich D, Kuo WP, Amphornrat J, Thilemann S, et al. 2013. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLOS Biol. 11:e1001604
73. Fünfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, et al. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517-21
74. Furusho M, Dupree JL, Nave KA, Bansal R. 2012. Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J. Neurosci. 32:6631-41
75. Furusho M, Kaga Y, Ishii A, Hebert JM, Bansal R. 2011. Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J. Neurosci. 31:5055-66
76. Gazzerro E, Baldassari S, Giacomini C, Musante V, Fruscione F, et al. 2012. Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein. PLOS ONE 7:e32180
77. Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, et al. 2014. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344(6183):1252304
78. Giese KP, Martini R, Lemke G, Soriano P, Schachner M. 1992. Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-76
79. Gieselmann V, Krageloh-Mann I. 2010. Metachromatic leukodystrophy: an update. Neuropediatrics 41:1-6
80. Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. 2011. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-alpha) on phagocytes. J. Neuroinflammation 8:24
81. Goebbels S, Oltrogge JH, Kemper R, Heilmann I, Bormuth I, et al. 2010. Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 30:8953-64
82. Goebbels S, Oltrogge JH, Wolfer S, Wieser GL, Nientiedt T, et al. 2012. Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol. Med. 4:486-99
83. Golan N, Kartvelishvily E, Spiegel I, Salomon D, Sabanay H, et al. 2013. Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy. J. Neurosci. 33:10950-61
84. Gould RM. 1977. Incorporation of glycoproteins into peripheral nerve myelin. J. Cell Biol. 75:326-38
85. Gould RM, Dawson RM. 1976. Incorporation of newly formed lecithin into peripheral nerve myelin. J. Cell Biol. 68:480-96
86. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, et al. 1999. CNS myelin and Sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99:649-59
87. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, et al. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-13
88. Grimsey N, Lin H, Trejo J. 2014. Endosomal signaling by protease-activated receptors. J. Methods Enzymol. 535:389-401
89. Grossmann KS, Wende H, Paul FE, Cheret C, Garratt AN, et al. 2009. The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development. Proc. Natl. Acad. Sci. USA 106:16704-9
90. Hagemeyer N, Goebbels S, Papiol S, Kastner A, Hofer S, et al. 2012. A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol. Med. 4:528-39
91. Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat JM. 2001. Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol. 101:129-39
92. Hammond TR, Gadea A, Dupree J, Kerninon C, Nait-Oumesmar B, et al. 2014. Astrocyte-derived endothelin-1 inhibits remyelination through Notch activation. Neuron 81:588-602
93. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, et al. 2008. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 451:1076-81
94. Harauz G, Ladizhansky V, Boggs JM. 2009. Structural polymorphism and multifunctionality of myelin basic protein. Biochemistry 48:8094-104
95. Harlow DE, Macklin WB. 2014. Inhibitors of myelination: ECM changes, CSPGs and PTPs. Exp. Neurol. 251:39-46
96. Harris JJ, Attwell D. 2012. The energetics of CNS white matter. J. Neurosci. 32:356-71
97. Hartline DK, Colman DR. 2007. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr. Biol. 17:R29-35
98. Hasse B, Bosse F, Muller HW. 2002. Proteins of peripheral myelin are associated with glycosphingolipid/ cholesterol-enriched membranes. J. Neurosci. Res. 69:227-32
99. He Y, Dupree J, Wang J, Sandoval J, Li J, et al. 2007. The transcription factor Yin Yang 1 is essential for oligodendrocyte progenitor differentiation. Neuron 55:217-30
100. Henneke M, Diekmann S, Ohlenbusch A, Kaiser J, Engelbrecht V, et al. 2009. RNASET2-deficient cystic leukoencephalopathy resembles congenital cytomegalovirus brain infection. Nat. Genet. 41:773-75
101. Hildebrand C, Bowe CM, Remahl IN. 1994. Myelination and myelin sheath remodelling in normal and pathological PNS nerve fibres. Prog. Neurobiol. 43:85-141
102. Hildebrand C, Remahl S, Persson H, Bjartmar C. 1993. Myelinated nerve fibres in the CNS. Prog. Neurobiol. 40:319-84
103. Hoftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, et al. 2010. Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia 58:1847-57
104. Hu X, Hicks CW, He W, Wong P, Macklin WB, et al. 2006. Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9:1520-25
105. Hughes EG, Kang SH, Fukaya M, Bergles DE. 2013. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 16:668-76
106. Huynh JL, Garg P, Thin TH, Yoo S, Dutta R, et al. 2014. Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat. Neurosci. 17:121-30
107. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, et al. 2006. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J. Neurosci. 26:8206-16
108. Ip CW, Kroner A, Crocker PR, Nave KA, Martini R. 2007. Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol. Dis. 25:105-11
109. Jahn O, Tenzer S, Bartsch N, Patzig J, Werner HB. 2013. Myelin proteome analysis: methods and implications for the myelin cytoskeleton. Neuromethods 79:335-53
110. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: molecular anatomy of an insulating sheath. Mol. Neurobiol. 40:55-72
111. Jalil MA, Begum L, Contreras L, Pardo B, Iijima M, et al. 2005. Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier. J. Biol. Chem. 280:31333-39
112. Jessen KR, Mirsky R. 2005. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6:671-82
113. Jessen KR, Mirsky R, Morgan L. 1991. Role of cyclic AMP and proliferation controls in Schwann cell differentiation. Ann. N.Y. Acad. Sci. 633:78-89
114. Jin F, Dong B, Georgiou J, Jiang Q, Zhang J, et al. 2011. N-WASp is required for Schwann cell cytoskeletal dynamics, normal myelin gene expression and peripheral nerve myelination. Development 138:1329-37
115. Kang SH, Li Y, Fukaya M, Lorenzini I, Cleveland DW, et al. 2013. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16:571-79
116. Kaplan MR, Meyer-Franke A, Lambert S, Bennett V, Duncan ID, et al. 1997. Induction of sodium channel clustering by oligodendrocytes. Nature 386:724-28
117. Kassmann CM. 2014. Myelin peroxisomes: essential organelles for the maintenance of white matter in the nervous system. Biochimie 98:111-18
118. Kassmann CM, Lappe-Siefke C, Baes M, Brugger B, Mildner A, et al. 2007. Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nat. Genet. 39:969-76
119. Kaul R, Gao GP, Balamurugan K, Matalon R. 1993. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 5:118-23
120. Kegel L, Jaegle M, Driegen S, Aunin E, Leslie K, et al. 2014. Functional phylogenetic analysis of LGI proteins identifies an interaction motif crucial for myelination. Development 141:1749-56
121. Keller TA, Just MA. 2009. Altering cortical connectivity: remediation-induced changes in the white matter of poor readers. Neuron 64:624-31
122. Kessaris N, Fogarty M, Iannarelli P, Grist M, Wegner M, Richardson WD. 2006. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat. Neurosci. 9:173-79
123. Kidd GJ, Andrews SB, Trapp BD. 1994. Organization of microtubules in myelinating Schwann cells. J. Neurocytol. 23:801-10
124. Kim HJ, DiBernardo AB, Sloane JA, Rasband MN, Solomon D, et al. 2006. WAVE1 is required for oligodendrocyte morphogenesis and normal CNS myelination. J. Neurosci. 26:5849-59
125. Kirby BB, Takada N, Latimer AJ, Shin J, Carney TJ, et al. 2006. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat. Neurosci. 9:1506-11
126. Kirschner DA, Ganser AL. 1980. Compact myelin exists in the absence of basic protein in the shiverer mutant mouse. Nature 283:207-10
127. Kolodziejczyk K, Saab AS, Nave KA, Attwell D. 2010. Why do oligodendrocyte lineage cells express glutamate receptors? F1000 Biol. Rep. 2:57
128. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J. Neurosci. 26:328-32
129. Kotter MR, Stadelmann C, Hartung HP. 2011. Enhancing remyelination in disease: Can we wrap it up? Brain 134:1882-900
130. Krämer-Albers E-M, Bretz N, Tenzer S, Winterstein C, Möbius W, et al. 2007. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons? Proteomics Clin. Appl. 1:1446-61
131. Krämer-Albers EM, White R. 2011. From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell. Mol. Life Sci. 68:2003-12
132. La Marca R, Cerri F, Horiuchi K, Bachi A, Feltri ML, et al. 2011. TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14:857-65
133. Laquerriere A, Maluenda J, Camus A, Fontenas L, Dieterich K, et al. 2014. Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects. Hum. Mol. Genet. 23:2279-89
134. Larson TA, Gordon TN, Lau HE, Parichy DM. 2010. Defective adult oligodendrocyte and Schwann cell development, pigment pattern, and craniofacial morphology in puma mutant zebrafish having an alpha tubulin mutation. Dev. Biol. 346:296-309
135. Lasiene J, Matsui A, Sawa Y, Wong F, Horner PJ. 2009. Age-related myelin dynamics revealed by increased oligodendrogenesis and short internodes. Aging Cell 8:201-13
136. Lee AG. 2001. Myelin: delivery by raft. Curr. Biol. 11:R60-62
137. Lee J, Gravel M, Zhang R, Thibault P, Braun PE. 2005. Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J. Cell Biol. 170:661-73
138. Lee S, Leach MK, Redmond SA, Chong SY, Mellon SH, et al. 2012. A culture system to study oligodendrocyte myelination processes using engineered nanofibers. Nat. Methods 9:917-22
139. Lee X, Yang Z, Shao Z, Rosenberg SS, Levesque M, et al. 2007. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 27:220-25
140. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, et al. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-48
141. Leegwater PA, Yuan BQ, van der Steen J, Mulders J, Konst AA, et al. 2001. Mutations of MLC1 (KIAA0027), encoding a putative membrane protein, cause megalencephalic leukoencephalopathy with subcortical cysts. Am. J. Hum. Genet. 68:831-38
142. Lenz PH, Hartline DK, Davis AD. 2000. The need for speed. I. Fast reactions and myelinated axons in copepods. J. Comp. Physiol. A 186:337-45
143. Li C, Tropak MB, Gerlai R, Clapoff S, Abramow-Newerly W, et al. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature 369:747-50
144. Li H, Richardson WD. 2008. The evolution of Olig genes and their roles in myelination. Neuron Glia Biol. 4:129-35
145. Liu J, Casaccia P. 2010. Epigenetic regulation of oligodendrocyte identity. Trends Neurosci. 33:193-201
146. Liu J, Dietz K, DeLoyht JM, Pedre X, Kelkar D, et al. 2012. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat. Neurosci. 15:1621-23
147. Locatelli G, Wortge S, Buch T, Ingold B, Frommer F, et al. 2012. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat. Neurosci. 15:543-50
148. Lopez-Hernandez T, Ridder MC, Montolio M, Capdevila-Nortes X, Polder E, et al. 2011. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism. Am. J. Hum. Genet. 88:422-32
149. Lopez-Verrilli MA, Picou F, Court FA. 2013. Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system. Glia 61:1795-806
150. Lundgaard I, Luzhynskaya A, Stockley JH, Wang Z, Evans KA, et al. 2013. Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytes. PLOS Biol. 11:e1001743
151. Lunn KF, Baas PW, Duncan ID. 1997. Microtubule organization and stability in the oligodendrocyte. J. Neurosci. 17:4921-32
152. Lyons DA, Naylor SG, Scholze A, Talbot WS. 2009. Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons. Nat. Genet. 41:854-58
153. Lyons DA, Pogoda HM, Voas MG, Woods IG, Diamond B, et al. 2005. erbb3 and erbb2 are essential for Schwann cell migration and myelination in zebrafish. Curr. Biol. 15:513-24
154. Makinodan M, Rosen KM, Ito S, Corfas G. 2012. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337:1357-60
155. Manrique-Hoyos N, Jurgens T, Gronborg M, Kreutzfeldt M, Schedensack M, et al. 2012. Late motor decline after accomplished remyelination: impact for progressive multiple sclerosis. Ann. Neurol. 71:227-44
156. Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL. 2006. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372-81
157. Martini R, Fischer S, Lopez-Vales R, David S. 2008. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 56:1566-77
158. Martini R, Mohajeri MH, Kasper S, Giese KP, Schachner M. 1995. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J. Neurosci. 15:4488-95
159. Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Harris LW, Bahn S. 2011. Proteomic technologies for biomarker studies in psychiatry: advances and needs. Int. Rev. Neurobiol. 101:65-94
160. Masaki T, Qu J, Cholewa-Waclaw J, Burr K, Raaum R, Rambukkana A. 2013. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 152:51-67
161. Mathews ES, Mawdsley DJ, Walker M, Hines JH, Pozzoli M, Appel B. 2014. Mutation of 3-hydroxy-3-methylglutaryl CoA synthase I reveals requirements for isoprenoid and cholesterol synthesis in oligodendrocyte migration arrest, axon wrapping, and myelin gene expression. J. Neurosci. 34:3402-12
162. Maxfield FR, van Meer G. 2010. Cholesterol, the central lipid of mammalian cells. Curr. Opin. Cell Biol. 22:422-9
163. McGee AW, Yang Y, Fischer QS, Daw NW, Strittmatter SM. 2005. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 309:2222-26
164. Mersmann N, Tkachev D, Jelinek R, Roth PT, Mobius W, et al. 2011. Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease. PLOS ONE 6:e20336
165. Meyer zu Horste G, Hartung HP, Kieseier BC. 2007. From bench to bedside: experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat. Clin. Pract. Neurol. 3:198-211
166. Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, et al. 2004. Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700-3
167. Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D. 2004. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol. Life Sci. 61:369-85
168. Min Y, Kristiansen K, Boggs JM, Husted C, Zasadzinski JA, Israelachvili J. 2009. Interaction forces and adhesion of supported myelin lipid bilayers modulated by myelin basic protein. Proc. Natl. Acad. Sci. USA 106:3154-59
169. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, et al. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16:1211-18
170. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW. 2007. Imaging axonal transport of mitochondria in vivo. Nat. Methods 4:559-61
171. Mitew S, Hay CM, Peckham H, Xiao J, Koenning M, Emery B. 2013. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience. Epub ahead of print; doi: 10.1016/j.neuroscience.2013.11.029
172. Möbius W, Patzig J, Nave KA, Werner HB. 2008. Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection. Neuron Glia Biol. 4:111-27
173. Mogha A, Benesh AE, Patra C, Engel FB, Schoneberg T, et al. 2013. Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation. J. Neurosci. 33:17976-85
174. Monk KR, Naylor SG, Glenn TD, Mercurio S, Perlin JR, et al. 2009. A G protein-coupled receptor is essential for Schwann cells to initiate myelination. Science 325:1402-5
175. Monk KR, Oshima K, Jors S, Heller S, Talbot WS. 2011. Gpr126 is essential for peripheral nerve development and myelination in mammals. Development 138:2673-80
176. Morato L, Galino J, Ruiz M, Calingasan NY, Starkov AA, et al. 2013. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain 136:2432-43
177. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, et al. 1993. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726-30
178. Müller C, Bauer NM, Schäfer I, White R. 2013. Making myelin basic protein: from mRNA transport to localized translation. Front. Cell. Neurosci. 7:169
179. Musse AA, Gao W, Homchaudhuri L, Boggs JM, Harauz G. 2008. Myelin basic protein as a “PI(4,5)P2-modulin”: a new biological function for a major central nervous system protein. Biochemistry 47:10372-82
180. Myllykoski M, Raasakka A, Han H, Kursula P. 2012. Myelin 2′,3′-cyclic nucleotide 3′-phosphodiesterase: active-site ligand binding and molecular conformation. PLOS ONE 7:e32336
181. Namboodiri AM, Peethambaran A, Mathew R, Sambhu PA, Hershfield J, et al. 2006. Canavan disease and the role of N-acetylaspartate in myelin synthesis. Mol. Cell. Endocrinol. 252:216-23
182. Nave KA. 2010. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 11:275-83
183. Nawaz S, Kippert A, Saab A, Werner HB, Lang T, et al. 2009. Phosphatidylinositol (4,5) bisphosphate regulates membrane targeting of myelin basic protein. J. Neurosci. 29:4794-807
184. Nawaz S, Schweitzer J, Jahn O, Werner HB. 2013. Molecular evolution of myelin basic protein, an abundant structural myelin component. Glia 61:1364-77
185. Newbern JM, Li X, Shoemaker SE, Zhou J, Zhong J, et al. 2011. Specific functions for ERK/MAPK signaling during PNS development. Neuron 69:91-105
186. Nguyen MV, Felice CA, Du F, Covey MV, Robinson JK, et al. 2013. Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. J. Neurosci. 33:18764-74
187. Nguyen T, Mehta NR, Conant K, Kim KJ, Jones M, et al. 2009. Axonal protective effects of the myelin-associated glycoprotein. J. Neurosci. 29:630-37
188. Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, et al. 2011. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17:495-99
189. Norton WT, Poduslo SE. 1973a. Myelination in rat brain: changes in myelin composition during brain maturation. J. Neurochem. 21:759-73
190. Norton WT, Poduslo SE. 1973b. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:749-57
191. Novak N, Bar V, Sabanay H, Frechter S, Jaegle M, et al. 2011. N-WASP is required for membrane wrapping and myelination by Schwann cells. J. Cell Biol. 192:243-50
192. Ogawa Y, Rasband MN. 2009. Proteomic analysis of optic nerve lipid rafts reveals new paranodal proteins. J. Neurosci. Res. 87:3502-10
193. Ohno N, Kidd GJ, Mahad D, Kiryu-Seo S, Avishai A, et al. 2011. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J. Neurosci. 31:7249-58
194. Oluich LJ, Stratton JA, Xing YL, Ng SW, Cate HS, et al. 2012. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J. Neurosci. 32:8317-30
195. Ozcelik M, Cotter L, Jacob C, Pereira JA, Relvas JB, et al. 2010. Pals1 is a major regulator of the epithelial-like polarization and the extension of the myelin sheath in peripheral nerves. J. Neurosci. 30:4120-31
196. Patzig J, Dworschak MS, Martens AK, Werner HB. 2014. Septins in the glial cells of the nervous system. Biol. Chem. 395:143-49
197. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, et al. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J. Neurosci. 31:16369-86
198. Penton AL, Leonard LD, Spinner NB. 2012. Notch signaling in human development and disease. Semin. Cell Dev. Biol. 23:450-57
199. Pereira JA, Lebrun-Julien F, Suter U. 2012. Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci. 35:123-34
200. Peters A. 1961. A radial component of central myelin sheaths. J. Biophys. Biochem. Cytol. 11:733-35
201. Peters A. 2002. The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 31:581-93
202. Pfeiffer SE, Warrington AE, Bansal R. 1993. The oligodendrocyte and its many cellular processes. Trends Cell Biol. 3:191-97
203. Philips T, Bento-Abreu A, Nonneman A, Haeck W, Staats K, et al. 2013. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 136:471-82
204. Piaton G, Aigrot MS, Williams A, Moyon S, Tepavcevic V, et al. 2011. Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 134:1156-67
205. Pogoda HM, Sternheim N, Lyons DA, Diamond B, Hawkins TA, et al. 2006. A genetic screen identifies genes essential for development of myelinated axons in zebrafish. Dev. Biol. 298:118-31
206. Pohl HB, Porcheri C, Mueggler T, Bachmann LC, Martino G, et al. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 31:1069-80
207. Prukop T, Epplen DB, Nientiedt T, Wichert SP, Fledrich R, et al. 2014. Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. Am. J. Hum. Genet. 94:533-46
208. Ransohoff RM, Engelhardt B. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12:623-35
209. Readhead C, Popko B, Takahashi N, Shine HD, Saavedra RA, et al. 1987. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48:703-12
210. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, Yamaai T, Lewin GR, Birchmeier C. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389:725-30
211. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D. 2011. Regulation of oligodendrocyte development and myelination by glucose and lactate. J. Neurosci. 31:538-48
212. Roach A, Takahashi N, Pravtcheva D, Ruddle F, Hood L. 1985. Chromosomal mapping of mouse myelin basic protein gene and structure and transcription of the partially deleted gene in shiverer mutant mice. Cell 42:149-55
213. Rodemer C, Thai TP, Brugger B, Kaercher T, Werner H, et al. 2003. Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice. Hum. Mol. Genet. 12:1881-95
214. Rosenberg SS, Kelland EE, Tokar E, De la Torre AR, Chan JR. 2008. The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc. Natl. Acad. Sci. USA 105:14662-67
215. Rosenbluth J, Nave KA, Mierzwa A, Schiff R. 2006. Subtle myelin defects in PLP-null mice. Glia 54:172-82
216. Rosenbluth J, Schiff R, Lam P. 2009. Effects of osmolality on PLP-null myelin structure: implications re axon damage. Brain Res. 1253:191-97
217. Rosetti CM, Maggio B, Oliveira RG. 2008. The self-organization of lipids and proteins of myelin at the membrane interface. Molecular factors underlying the microheterogeneity of domain segregation. Biochim. Biophys. Acta 1778:1665-75
218. Roussos P, Haroutunian V. 2014. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities. Front. Cell. Neurosci. 8:5
219. Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, et al. 2012. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 10(1):96-103
220. Ruskamo S, Chukhlieb M, Vahokoski J, Bhargav SP, Liang F, et al. 2012. Juxtanodin is an intrinsically disordered F-actin-binding protein. Sci. Rep. 2:899
221. Ruskamo S, Yadav RP, Sharma S, Lehtimaki M, Laulumaa S, et al. 2014. Atomic resolution view into the structure-function relationships of the human myelin peripheral membrane protein P2. Acta Crystallogr. D 70:165-76
222. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, et al. 2005. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8:468-75
223. Saher G, Quintes S, Mobius W, Wehr MC, Kramer-Albers EM, et al. 2009. Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J. Neurosci. 29:6094-104
224. Saher G, Rudolphi F, Corthals K, Ruhwedel T, Schmidt KF, et al. 2012. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat. Med. 18:1130-35
225. Salzer JL, Brophy PJ, Peles E. 2008. Molecular domains of myelinated axons in the peripheral nervous system. Glia 56:1532-40
226. Sampaio-Baptista C, Khrapitchev AA, Foxley S, Schlagheck T, Scholz J, et al. 2013. Motor skill learning induces changes in white matter microstructure and myelination. J. Neurosci. 33:19499-503
227. Sanchez-Abarca LI, Tabernero A, Medina JM. 2001. Oligodendrocytes use lactate as a source of energy and as a precursor of lipids. Glia 36:321-29
228. Saporta MA, Shy ME. 2013. Inherited peripheral neuropathies. Neurol. Clin. 31:597-619
229. Saravanan K, Schaeren-Wiemers N, Klein D, Sandhoff R, Schwarz A, et al. 2004. Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol. Dis. 16:396-406
230. Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, et al. 1994. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat. Genet. 6:257-62
231. Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, et al. 2004. The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J. Cell Biol. 166:731-42
232. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. 2009. Training induces changes in white-matter architecture. Nat. Neurosci. 12:1370-71
233. Sherman DL, Wu LM, Grove M, Gillespie CS, Brophy PJ. 2012. Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth. J. Neurosci. 32:9419-28
234. Sierra A, Abiega O, Shahraz A, Neumann H. 2013. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front. Cell. Neurosci. 7:6
235. Simons M, Kramer EM, Thiele C, Stoffel W, Trotter J. 2000. Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J. Cell Biol. 151:143-54
236. Simpson AH, Gillingwater TH, Anderson H, Cottrell D, Sherman DL, et al. 2013. Effect of limb lengthening on internodal length and conduction velocity of peripheral nerve. J. Neurosci. 33:4536-39
237. Skripuletz T, Hackstette D, Bauer K, Gudi V, Pul R, et al. 2013. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain 136:147-67
238. Sloane JA, Vartanian TK. 2007. Myosin Va controls oligodendrocyte morphogenesis and myelination. J. Neurosci. 27:11366-75
239. Snaidero N, Mobius W, Czopka T, Hekking LH, Mathisen C, et al. 2014. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 156:277-90
240. Soong BW, Huang YH, Tsai PC, Huang CC, Pan HC, et al. 2013. Exome sequencing identifies GNB4 mutations as a cause of dominant intermediate Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 92:422-30
241. Southwood CM, Peppi M, Dryden S, Tainsky MA, Gow A. 2007. Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res. 32:187-95
242. Sparrow N, Manetti ME, Bott M, Fabianac T, Petrilli A, et al. 2012. The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J. Neurosci. 32:5284-97
243. Stolt CC, Rehberg S, Ader M, Lommes P, Riethmacher D, et al. 2002. Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16:165-70
244. Stroobants S, Gerlach D, Matthes F, Hartmann D, Fogh J, et al. 2011. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy. Hum. Mol. Genet. 20:2760-69
245. Sturrock RR. 1976. Changes in neurologia and myelination in the white matter of aging mice. J. Gerontol. 31:513-22
246. Suresh S, Wang C, Nanekar R, Kursula P, Edwardson JM. 2010. Myelin basic protein and myelin protein 2 act synergistically to cause stacking of lipid bilayers. Biochemistry 49:3456-63
247. Suzuki K, Rasband MN. 2008. Molecular mechanisms of node of Ranvier formation. Curr. Opin. Cell Biol. 20(6):616-23
248. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, et al. 2011. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144:810-23
249. Swiss VA, Nguyen T, Dugas J, Ibrahim A, Barres B, et al. 2011. Identification of a gene regulatory network necessary for the initiation of oligodendrocyte differentiation. PLOS ONE 6:e18088
250. Syed YA, Hand E, Mobius W, Zhao C, Hofer M, et al. 2011. Inhibition of CNS remyelination by the presence of semaphorin 3A. J. Neurosci. 31:3719-28
251. Taft RJ, Vanderver A, Leventer RJ, Damiani SA, Simons C, et al. 2013. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am. J. Hum. Genet. 92:774-80
252. Tamnes CK, Ostby Y, Walhovd KB, Westlye LT, Due-Tonnessen P, Fjell AM. 2010. Neuroanatomical correlates of executive functions in children and adolescents: a magnetic resonance imaging (MRI) study of cortical thickness. Neuropsychologia 48:2496-508
253. Tao Y, Dai P, Liu Y, Marchetto S, Xiong WC, et al. 2009. Erbin regulates NRG1 signaling and myelination. Proc. Natl. Acad. Sci. USA 106:9477-82
254. Tapinos N, Ohnishi M, Rambukkana A. 2006. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat. Med. 12:961-66
255. Tasaki I. 1939. The electro-saltatory transmission of the nerve impulse and the effect of narcosis upon the nerve fiber. Am. J. Physiol. 127:211-27
256. Tasaki I. 2007. Saltatory conduction. Scholarpedia 2(6):3354. http://www.scholarpedia.org/article/ Saltatory_conduction
257. Taveggia C, Feltri ML, Wrabetz L. 2010. Signals to promote myelin formation and repair. Nat. Rev. Neurol. 6:276-87
258. Taveggia C, Thaker P, Petrylak A, Caporaso GL, Toews A, et al. 2008. Type III neuregulin-1 promotes oligodendrocyte myelination. Glia 56:284-93
259. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, et al. 2005. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681-94
260. Timmerman V, Clowes VE, Reid E. 2013. Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp. Neurol. 246:14-25
261. Tomassy GS, Berger DR, Chen HH, Kasthuri N, Hayworth KJ, et al. 2014. Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex. Science 344(6181):319-24
262. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, et al. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-99
263. Torvund-Jensen J, Steengaard J, Reimer L, Fihl LB, Laursen LS. 2014. Transport and translation of MBP mRNA is regulated differently by distinct hnRNP proteins. J. Cell Sci. 127:1550-64
264. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-85
265. Triolo D, Dina G, Taveggia C, Vaccari I, Porrello E, et al. 2012. Vimentin regulates peripheral nerve myelination. Development 139:1359-67
266. Tripathi RB, Clarke LE, Burzomato V, Kessaris N, Anderson PN, et al. 2011. Dorsally and ventrally derived oligodendrocytes have similar electrical properties but myelinate preferred tracts. J. Neurosci. 31:6809-19
267. Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, et al. 2004. Mutations in the gene encoding gap junction protein α12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am. J. Hum. Genet. 75:251-60
268. van Meer G, Voelker DR, Feigenson GW. 2008. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9:112-24
269. Vavlitou N, Sargiannidou I, Markoullis K, Kyriacou K, Scherer SS, Kleopa KA. 2010. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J. Neuropathol. Exp. Neurol. 69:945-58
270. Velanac V, Unterbarnscheidt T, Hinrichs W, Gummert MN, Fischer TM, et al. 2012. Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia 60:203-17
271. Velumian AA, Samoilova M, Fehlings MG. 2011. Visualization of cytoplasmic diffusion within living myelin sheaths of CNS white matter axons using microinjection of the fluorescent dye Lucifer Yellow. Neuroimage 56:27-34
272. Verrier JD, Jackson TC, Gillespie DG, Janesko-Feldman K, Bansal R, et al. 2013. Role of CNPase in the oligodendrocytic extracellular 2′,3′-cAMP-adenosine pathway. Glia 61:1595-606
273. Vigano F, Mobius W, Gotz M, Dimou L. 2013. Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain. Nat. Neurosci. 16:1370-72
274. Wake H, Lee PR, Fields RD. 2011. Control of local protein synthesis and initial events in myelination by action potentials. Science 333:1647-51
275. Walko G, Wogenstein KL, Winter L, Fischer I, Feltri ML, Wiche G. 2013. Stabilization of the dystroglycan complex in Cajal bands of myelinating Schwann cells through plectin-mediated anchorage to vimentin filaments. Glia 61:1274-87
276. Wang JT, Medress ZA, Barres BA. 2012. Axon degeneration: molecular mechanisms of a self-destruction pathway. J. Cell Biol. 196:7-18
277. Wang SS, Shultz JR, Burish MJ, Harrison KH, Hof PR, et al. 2008. Functional trade-offs in white matter axonal scaling. J. Neurosci. 28:4047-56
278. Wanner IB, Wood PM. 2002. N-cadherin mediates axon-aligned process growth and cell-cell interaction in rat Schwann cells. J. Neurosci. 22:4066-79
279. Weng Q, Chen Y, Wang H, Xu X, Yang B, et al. 2012. Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 73:713-28
280. Werner HB. 2013. Do we have to reconsider the evolutionary emergence of myelin? Front. Cell. Neurosci. 7:217
281. Werner HB, Jahn O. 2010. Myelin matters: proteomic insights into white matter disorders. Expert Rev. Proteomics 7:159-64
282. Werner HB, Kramer-Albers EM, Strenzke N, Saher G, Tenzer S, et al. 2013. A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system. Glia 61:567-86
283. Werner HB, Kuhlmann K, Shen S, Uecker M, Schardt A, et al. 2007. Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci. 27:7717-30
284. White R, Kramer-Albers EM. 2014. Axon-glia interaction and membrane traffic in myelin formation. Front. Cell. Neurosci. 7:284
285. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, et al. 2010. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem. J. 425:127-36
286. Wibom R, Lasorsa FM, Tohonen V, Barbaro M, Sterky FH, et al. 2009. AGC1 deficiency associated with global cerebral hypomyelination. N. Engl. J. Med. 361:489-95
287. Wiesinger H, Hamprecht B, Dringen R. 1997. Metabolic pathways for glucose in astrocytes. Glia 21:22-34
288. Wilkins A, Majed H, Layfield R, Compston A, Chandran S. 2003. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J. Neurosci. 23:4967-74
289. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, et al. 2006. Control of peripheral nerve myelination by the β-secretase BACE1. Science 314:664-66
290. Wilson CH, Hartline DK. 2011. Novel organization and development of copepod myelin. II. Nonglial origin. J. Comp. Neurol. 519:3281-305
291. Winzeler AM, Mandemakers WJ, Sun MZ, Stafford M, Phillips CT, Barres BA. 2011. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J. Neurosci. 31:6481-92
292. Woldeyesus MT, Britsch S, Riethmacher D, Xu L, Sonnenberg-Riethmacher E, et al. 1999. Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev. 13:2538-48
293. Wong AW, Xiao J, Kemper D, Kilpatrick TJ, Murray SS. 2013. Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation. J. Neurosci. 33:4947-57
294. Wong LJ. 2012. Mitochondrial syndromes with leukoencephalopathies. Semin. Neurol. 32:55-61
295. Woodhoo A, Alonso MB, Droggiti A, Turmaine M, D'Antonio M, et al. 2009. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat. Neurosci. 12:839-47
296. Yin X, Baek RC, Kirschner DA, Peterson A, Fujii Y, et al. 2006. Evolution of a neuroprotective function of central nervous system myelin. J. Cell Biol. 172:469-78
297. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, et al. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J. Neurosci. 18:1953-62
298. Yoshida M, Colman DR. 1996. Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin. Neuron 16:1115-26
299. Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, et al. 2013. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77:873-85
300. Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, et al. 2013. Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain 136:1035-47
301. Yurlova L, Kahya N, Aggarwal S, Kaiser HJ, Chiantia S, et al. 2011. Self-segregation of myelin membrane lipids in model membranes. Biophys. J. 101:2713-20
302. Zalc B, Goujet D, Colman D. 2008. The origin of the myelination program in vertebrates. Curr. Biol. 18:R511-12
303. Zeis T, Schaeren-Wiemers N. 2008. Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis. J. Mol. Neurosci. 35:91-100
304. Zenker J, Ziegler D, Chrast R. 2013. Novel pathogenic pathways in diabetic neuropathy. Trends Neurosci. 36(8):439-49
305. Zuchero JB, Barres BA. 2013. Intrinsic and extrinsic control of oligodendrocyte development. Curr. Opin. Neurobiol. 23:914-20